Harvest Exchange Completes $5 Million Series B Funding Round
June 18, 2015 10:57 ET
|
Harvest Exchange Corp.
HOUSTON, June 18, 2015 (GLOBE NEWSWIRE) -- Harvest Exchange (HVST.com), the fast-growing investment management marketplace platform today announced a $5 million Series B funding round led by Highland...
Cummins Inc. Declares Quarterly Common Stock Dividend
May 12, 2015 14:55 ET
|
Cummins, Inc.
COLUMBUS, Ind., May 12, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Cummins Inc. (NYSE: CMI) today declared a quarterly common stock cash dividend of 78 cents per share, payable on June 1,...
Photo Release -- Nasdaq Welcomes Etsy, Inc. (Nasdaq: ETSY) to The Nasdaq Stock Market
April 16, 2015 12:39 ET
|
Nasdaq, Inc.
NEW YORK, April 16, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of Etsy, Inc. (Nasdaq:ETSY) commenced on The Nasdaq Stock Market on April 16, 2015. A photo accompanying...
Hemispherx Biopharma Awarded $770,852 by Federal Judge
January 15, 2015 08:30 ET
|
AIM ImmunoTech Inc.
WILMINGTON, Del., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that after prevailing in a federal lawsuit brought against the...
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus
November 03, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
Hemispherx Biopharma Reports New Evidence -- Based Potential of Ampligen(R) Against Ebola Virus Disease (EVD)
October 30, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), reported today a new peer reviewed publication entitled, "The Quest for...
Big Screen Entertainment Group Holds Board Meeting - Class B Stock of 35,000,000 to Return to BSEG Treasury
September 04, 2014 13:16 ET
|
Big Screen Entertainment Group
LOS ANGELES, CA--(Marketwired - Sep 4, 2014) - Big Screen Entertainment (PINKSHEETS: BSEG) is pleased to announce new resolutions have been adopted by the Board of Directors to tighten up the...
Hemispherx Biopharma to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
September 03, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) today announced it will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global...
Hemispherx Biopharma Announces Financial Results for the Six Months Ended June 30, 2014
August 11, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the six months ended June 30, 2014. The net loss (including non-cash effects) was...
Big Screen Entertainment Group Acquires Thrilling Script From Taj Jackson/Sco Triplets
May 30, 2014 19:16 ET
|
Big Screen Entertainment Group
HOLLYWOOD, CA--(Marketwired - May 30, 2014) - Big Screen Entertainment Group (PINKSHEETS: BSEG) has optioned the rights to the new script by Taj Jackson, nephew of Michael Jackson, and the Brazilian...